Rtw Investments as of Dec. 31, 2014
Portfolio Holdings for Rtw Investments
Rtw Investments holds 21 positions in its portfolio as reported in the December 2014 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Taro Pharmaceutical Inds SHS (TARO) | 14.7 | $40M | 268k | 148.19 | |
| Alnylam Pharmaceuticals (ALNY) | 12.2 | $33M | 340k | 97.00 | |
| Dyax | 11.1 | $30M | 2.1M | 14.06 | |
| BioCryst Pharmaceuticals (BCRX) | 10.2 | $28M | 2.3M | 12.16 | |
| Achillion Pharmaceuticals | 7.4 | $20M | 1.6M | 12.25 | |
| La Jolla Pharmaceutical Com Par $.0001 2 | 7.3 | $20M | 1.1M | 18.45 | |
| Arrowhead Resh Corp Com New | 7.1 | $19M | 2.6M | 7.38 | |
| Dicerna Pharmaceuticals | 6.8 | $18M | 1.1M | 16.47 | |
| Zs Pharma | 5.8 | $16M | 375k | 41.57 | |
| Relypsa | 5.1 | $14M | 450k | 30.80 | |
| XenoPort | 2.7 | $7.4M | 843k | 8.77 | |
| Vanda Pharmaceuticals (VNDA) | 2.6 | $7.2M | 500k | 14.32 | |
| Targacept | 2.6 | $7.0M | 2.7M | 2.63 | |
| Avalanche Biotechnologies In | 1.0 | $2.7M | 50k | 54.00 | |
| Repros Therapeutics Com New | 0.8 | $2.3M | 229k | 9.97 | |
| Cytrx Corp Com Par $.001 | 0.7 | $1.9M | 705k | 2.74 | |
| Assembly Biosciences | 0.6 | $1.6M | 204k | 7.86 | |
| Protalix BioTherapeutics | 0.6 | $1.6M | 844k | 1.84 | |
| Lipocine | 0.4 | $1.1M | 209k | 5.26 | |
| Nevro (NVRO) | 0.2 | $594k | 15k | 38.68 | |
| Lpath Com New | 0.1 | $169k | 60k | 2.82 |
